From 2013 to 2023, the pharmaceutical industry trade balance in Sweden has shown a fluctuating trend, peaking in 2020 at $6.99 billion and experiencing a decline in 2021 to $5.64 billion. As of 2023, the trade balance stands at $5.92 billion. The average annual growth rate (CAGR) over the last five years is 4.55%. Despite the annual growth rate dip in some years, there has been an overall positive trend with notable year-on-year variations, including periods of significant growth and occasional decline.

Future trends to watch for include:

Continued steady growth with a forecasted CAGR of 1.5% from 2024 to 2028.
Sustained improvements in trade balance, projecting to reach $6.51 billion by 2028.
Potential influences of global market dynamics, regulatory changes, and innovations in pharmaceuticals on trade performance.